February 16, 2022
DOMINIC CLARKE, CTO OF CELL AND GENE THERAPIES AT DISCOVERY LIFE SCIENCES DISCUSSES THE IMPORTANCE OF A DIVERSE AND RELIABLE DONOR POOL IN THE DEVELOPMENT OF CELL THERAPIES, AND CONSIDERS THE SIGNIFICANCE OF THIS CONSISTENCY WHEN TRANSITIONING TO GMP-COMPLIANT PROCESSES.
